News

June in Review: 14 Top Health Press Releases
With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...
Asianet Newsable on MSN2h
Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy
The FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical ...
TipRanks on MSN13h
Klotho Neurosciences Receives FDA Orphan Drug Designation
Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025, Klotho Neurosciences announced that the FDA granted Orphan Drug ...
Klotho Stock Delivers 1,222% Biotech Blowout: Opportunity or Bubble?
Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.
Klotho Neurosciences stock soars after FDA grants orphan drug status for ALS
Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...
US Stocks Likely To Open Lower A Day After Nasdaq Hits Record High: Nvidia, Kellogg, Klotho In Focus
U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading ...
New Anti-Aging Gene Therapy Extends Lifespan by up to 20%
Boosting Klotho protein levels in mice improves physical and cognitive aging, offering potential for future longevity ...
ALS News Today2d
Klotho advances ALS gene therapy KLTO‑202 to manufacturing phase
Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...